Product Information

LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.0370 per EA under NDC 69097096912. Its NADAC has been published 317 times since Jun 3, 2020.

LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB

Lisinopril and Hydrochlorothiazide Tablets
$0.0370per EA

Strength

12.5; 20 mg/1; mg/1

Manufacturer

Cipla USA Inc.

NDC

69097096912

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204058

On Market Since

12/26/2019

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 317 times since Jun 3, 2020, and over the history we have for it it has declined 24.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0370 per EA
All-time high$0.0587 (Oct 13, 2021)
All-time low$0.0311 (Nov 20, 2024)
52-week high$0.0413
52-week low$0.0368
Median price$0.0470
Average price$0.0462
Largest weekly change-29.0% (Nov 20, 2024)
Weeks tracked317
Tracking sinceJun 3, 2020

Price History

1W

0.0%

1M

-0.1%

3M

-1.6%

6M

-10.5%

1Y

-10.0%

3Y

-23.9%

5Y

-32.2%

All

-24.1%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Cipla USA Inc., is $0.0370 per EA (NDC 69097096912), effective Jun 24, 2026.

How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 24.1%. It has been tracked across 317 weekly CMS publications since Jun 3, 2020.

What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

Since Jun 3, 2020, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.0311 (Nov 20, 2024) to a high of $0.0587 (Oct 13, 2021), with a median of $0.0470 per EA.

Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

3 NADAC-published products share the same active ingredient, strength, and dosage form as LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, but none are currently priced below it.

Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 69097096912) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.